DIMAZON 50 MG/ML SOLUTION FOR INJECTION
Страна: Ірландія
мова: англійська
Джерело: HPRA (Health Products Regulatory Authority)
Характеристики продукта
(SPC)
15-07-2016
Деякі документи на цей товар наразі недоступні. Ви можете надіслати запит до нашої служби підтримки, і ми повідомимо вас, як тільки ми зможемо їх отримати.
Відправляти запит.
Відправляти запит.
Активний інгредієнт:
FUROSEMIDE
Доступна з:
Intervet Ireland Limited
Код атс:
QC03CA01
ІПН (Міжнародна Ім'я):
FUROSEMIDE
Дозування:
50 Mg/Ml
Фармацевтична форма:
Solution for Injection
Тип рецепту:
POM
Терапевтична група:
Bovine, Canine, Equine - Food, Feline
Терапевтична области:
Furosemide
Терапевтичні свідчення:
Cardiovascular
Статус Авторизація:
Authorised
Дата Авторизація:
1995-10-01
Характеристики продукта
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Dimazon 50 mg/ml Solution for Injection
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
For a full list of excipients see section 6.1.
3 PHARMACEUTICAL FORM
Solution for injection.
A slightly yellowing fluid
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cattle, horses, dogs and cats
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Supportive therapy in all cases in which non inflammatory accumulation of fluid of various origins should be
reabsorbed from tissue body cavities, joints, tendon sheaths etc. by means of increased diuresis/saluresis e.g. oedema
associated with cardiac insufficiency, renal dysfunction, trauma and parasitic disease. It is also recommended for the
treatment of mammary oedema and limb oedema.
4.3 CONTRAINDICATIONS
Do not use in cases of liver coma, renal deficiency with anuria, electrolyte deficiency (hypokalemia, hyponatremia),
hypotony and sulfonamide allergy.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
Clinical experience with dogs indicates that improved results can be frequently achieved by supplementary
administration of corticosteroids.
Each ml contains:
ACTIVE SUBSTANCE
Furosemide
50 mg
(as monoethanolamine salt)
EXCIPIENTS:
Benzyl alcohol
15.0 mg
Sodium sulphite, anhydrous
1.8 mg
HEALTH PRODUCTS REGULATORY AUTHORITY
________________________________________________________________________________________________________________________
_Date Printed 30/06/2016_
_CRN 7023977_
_page number: 1_
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
When cardiac glycosides are used, furosemide should be applied only for the first 3 days.
In dogs after a simultaneous use of furosemide and digoxin preparations an undesired increased digoxin-effect may
occur. Therefore it is recommended to reduce the digox
Прочитайте повний документ
